NYSE ARCA | ETF
The fund invests primarily in a diverse group ofU. S. companies in market sectors and industry groups the portfolio managers expect to appreciate in value if theU. S. inflation rate rises or is believed to be rising.
Under normal market conditions, the fund will invest at least 80% of its assets in equity securities.
The fund may invest in companies of all market capitalizations.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 7.46% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 4.93% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.26% |
| PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 3.80% |
| KO | The Coca-Cola Company | Consumer Defensive | Beverages - Non-Alcoholic | 2.81% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 2.76% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 2.55% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.35% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.22% |
| PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 2.02% |
| PGR | Progressive Corp | Financial Services | Insurance - Property & Casualty | 1.80% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.50% |
| COP | ConocoPhillips | Energy | Oil & Gas E&P | 1.48% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.38% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 1.35% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.33% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.12% |
| CB | Chubb Ltd | Financial Services | Insurance - Property & Casualty | 1.09% |
| CL | Colgate-Palmolive Company | Consumer Defensive | Household & Personal Products | 1.08% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.07% |